TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7950226

Group type: EXPERIMENTAL
Intervention: Spleen Qi and Kidney Qi Deficiency (SQKQD) group
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both Qi and Yin Deficiency (QYD) group
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Liver Yin and Kidney Yin Deficiency (LYKYD) group
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: With-Dampness group
Number of subjects: 132

Group type: COMPARATOR
Intervention: Without-Dampness group
Number of subjects: 132
Study: 3311100

Group type: EXPERIMENTAL
Intervention: Subarachnoid blockade
Number of subjects: 538

Group type: COMPARATOR
Intervention: General (narcotic-relaxant) anaesthesia
Number of subjects: 538
Study: 31448488

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Percutaneous Neuromodulation (PNM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison between TENS and PNM
Number of subjects: 32
Study: 30130574

Group type: EXPERIMENTAL
Intervention: 0.2% Chlorhexidine gluconate + Light Activated Disinfection (LAD)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Diode laser irradiation (810 nm, 2 W)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Disinfection protocols (various methods)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: All evaluated methods
Number of subjects: 76
Study: 27619015

Group type: EXPERIMENTAL
Intervention: Standard mobilization with physiotherapists
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MOTOmed‐letto® protocol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Erigo® protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 30
Study: 23922010

Group type: EXPERIMENTAL
Intervention: High-saturated fatty acid (HSFA) diet for 12 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet supplemented with placebo (LFHCC) for 12 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet supplemented with long-chain n-3 fatty acids (LFHCC n-3) for 12 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (HMUFA) diet for 12 weeks
Number of subjects: 39
Study: 22201658

Group type: EXPERIMENTAL
Intervention: Telephone calls from a peer counselor once per week for five weeks beginning within 72 hours postsurgery
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Telephone calls from a peer counselor once weekly for five weeks beginning six weeks postsurgery
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Telephone calls from a peer counselor by request
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 142
Study: 20353612

Group type: EXPERIMENTAL
Intervention: Peer role play (RP)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Standardised patients (SP)
Number of subjects: 69
Study: 18694405

Group type: EXPERIMENTAL
Intervention: Peer-assisted learning (PAL) by Year 6 students
Number of subjects: 131

Group type: COMPARATOR
Intervention: Qualified tutors (paid doctors)
Number of subjects: 131
Study: 15962676

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mebendazole (500 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Praziquantel (40 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12883542

Group type: EXPERIMENTAL
Intervention: Twice-weekly supervised exercise training
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Follow-up at 3 months after RCT
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Correlation between pain and exercise adherence
Number of subjects: 7
Study: 10691072

Group type: EXPERIMENTAL
Intervention: Mandibular Series (MS)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Pantomographic Series (PS)
Number of subjects: 54
Study: 9496215

Group type: EXPERIMENTAL
Intervention: Electric blanket group (n = 10)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (n = 8)
Number of subjects: 18
Study: 7678043

Group type: EXPERIMENTAL
Intervention: Nilutamide
Number of subjects: 457

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study: 3753363

Group type: EXPERIMENTAL
Intervention: Spironolactone (S) 25 mg orally, four times per day
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 9
Study: 29128192

Group type: EXPERIMENTAL
Intervention: benralizumab 30 mg Q4W
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: benralizumab 30 mg Q8W
Number of subjects: 83

Group type: COMPARATOR
Intervention: placebo Q4W
Number of subjects: 83
Study: 27737722

Group type: EXPERIMENTAL
Intervention: Ex-diet group (improved fat quality diet)
Number of subjects: 115

Group type: COMPARATOR
Intervention: C-diet group (control diet)
Number of subjects: 115
Study: 24628682

Group type: EXPERIMENTAL
Intervention: Risky single-occasion drinking
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Private home drinking
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Drinking with friends
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Number of drinking locations
Number of subjects: 802
Study: 24047061

Group type: EXPERIMENTAL
Intervention: Midurethral-sling surgery
Number of subjects: 460

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 460
Study: 20027034

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 149

Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 149
Study: 18420764

Group type: EXPERIMENTAL
Intervention: Postpartum smoking cessation and relapse prevention intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 15879332

Group type: EXPERIMENTAL
Intervention: Eprosartan
Number of subjects: 1405

Group type: COMPARATOR
Intervention: Nitrendipine
Number of subjects: 1405
Study: 12649124

Group type: EXPERIMENTAL
Intervention: SCH55700 1.0 mg/kg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SCH55700 0.3 mg/kg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 11194275

Group type: EXPERIMENTAL
Intervention: Bupropion (300 mg delayed release for 7 to 9 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bupropion plus nicotine patch
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nicotine patch
Number of subjects: 0
Study: 8773551

Group type: EXPERIMENTAL
Intervention: Innovative home-health nursing intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 22
Study: 31211375

Group type: EXPERIMENTAL
Intervention: Genetically predicted PCOS
Number of subjects: 22406
Study: 30561264

Group type: EXPERIMENTAL
Intervention: Combined treatment (simvastatin + ezetimibe)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 40
Study: 27346837

Group type: EXPERIMENTAL
Intervention: Behavioural intervention promoting an active lifestyle, based on motivational interviewing
Number of subjects: 39
Study: 24408305

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg ISU303
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg ISU303
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 22115011

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10mg (E)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Simvastatin 20mg (S)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Combination of ezetimibe/simvastatin 10/20mg (C)
Number of subjects: 40
Study: 18207121

Group type: EXPERIMENTAL
Intervention: 1% atropine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Optical penalization with positive lenses
Number of subjects: 70
Study: 16504368

Group type: EXPERIMENTAL
Intervention: Tibolone (Livial) 2.5 mg/day + Alendronate sodium (Fosamax) 10 mg/day
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alendronate sodium (Fosamax) 10 mg/day
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 32
Study: 14673681

Group type: EXPERIMENTAL
Intervention: Endoscopic sympathetic block (ESB) at T2
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Endoscopic sympathetic block (ESB) at T4
Number of subjects: 22
Study: 11142075

Group type: EXPERIMENTAL
Intervention: Arthritis Self-Management Programme (ASMP)
Number of subjects: 544
Study: 9354202

Group type: EXPERIMENTAL
Intervention: 1-week triple therapy of omeprazole 20 mg b.d., clarithromycin 250 mg b.d. and tetracycline 500 mg b.d. (OCT)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: 2-week dual therapy of omeprazole 20 mg b.d. and amoxycillin 1 g b.d. (OA)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Retreatment with OA regimen after OCT failure
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Retreatment with OCT therapy after OA failure
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Overall success rate for triple and dual therapy sequence
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Overall success rate for dual followed by triple therapy
Number of subjects: 153
Study: 8250615

Group type: EXPERIMENTAL
Intervention: Colchicine (0.6‐1.8 mg/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 25
Study: 3457171

Group type: EXPERIMENTAL
Intervention: 1.23% acidulated phosphate fluoride gel
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 8% stannous fluoride
Number of subjects: 57

Group type: COMPARATOR
Intervention: 0.05% sodium fluoride solution
Number of subjects: 57

Group type: COMPARATOR
Intervention: 0.2% sodium fluoride solution
Number of subjects: 57

Group type: COMPARATOR
Intervention: 2% sodium fluoride solution
Number of subjects: 57

Group type: COMPARATOR
Intervention: 0.4% stannous fluoride gel
Number of subjects: 57
Study: 30390943

Group type: EXPERIMENTAL
Intervention: Intraperitoneal carboplatin (AUC 6) every 3 weeks with intravenous paclitaxel weekly at 80 mg/m2
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Intraperitoneal carboplatin and intravenous paclitaxel
Number of subjects: 49
Study: 26956031

Group type: EXPERIMENTAL
Intervention: Small deep infarct (lacunar)
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Paramedian wedge
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Atypical paramedian
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Other
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Old lacunes on T1/fluid-attenuated inversion recovery
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Intracranial stenosis ≥50%
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Recurrent stroke or death
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Assigned treatment
Number of subjects: 644
Study: 24127851

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics with single-dose i.v. cefazolin (1 g)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics with single-dose i.v. ceftriaxone (1 g)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics with oral levofloxacin (500 mg)
Number of subjects: 206

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (all types)
Number of subjects: 206
Study: 22736124

Group type: EXPERIMENTAL
Intervention: Non-antibiotics restriction group
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Bowel preparation group
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Postoperative fasting group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Antibiotic restriction group
Number of subjects: 64
Study: 20077053

Group type: EXPERIMENTAL
Intervention: tesofensine
Number of subjects: 62

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 62
Study: 18377127

Group type: COMPARATOR
Intervention: Brief advice (10 min)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: MET plus cognitive-behavioral therapy (CBT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Assessment only control
Number of subjects: 180
Study: 16898079

Group type: COMPARATOR
Intervention: r-hIL-18 BP (20, 70, 210 or 350 mg, sc)
Number of subjects: 105

Group type: COMPARATOR
Intervention: r-hIL-18 BP (35 or 175 mg, sc, 6 injections, 48 h apart)
Number of subjects: 105

Group type: COMPARATOR
Intervention: r-hIL-18 BP (20, 160 or 320 mg, sc tiw)
Number of subjects: 105

Group type: COMPARATOR
Intervention: r-hIL-18 BP (20, 80, 160 mg, sc tiw)
Number of subjects: 105
Study: 14593351

Group type: EXPERIMENTAL
Intervention: Bisoprolol (1.25‐10 mg/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 10938496

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0
Study: 8999617

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure for men age < 50
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Night time ambulatory blood pressure for men age < 50
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure for women age < 50
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Night time ambulatory blood pressure for women age < 50
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure for men age >= 50
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Night time ambulatory blood pressure for men age >= 50
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure for women age >= 50
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Night time ambulatory blood pressure for women age >= 50
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure corresponding to WHO's upper limit for normal blood pressure (clinic)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Night time ambulatory blood pressure corresponding to WHO's upper limit for normal blood pressure (clinic)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure corresponding to clinic pressure of 95 mmHg
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure corresponding to clinic pressure of 100 mmHg
Number of subjects: 352
Study: 1335442

Group type: EXPERIMENTAL
Intervention: L-carnitine during ECC
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: L-carnitine before and during ECC
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sodium bicarbonate
Number of subjects: 120
Study: 6373679

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 12
Study: 29685023

Group type: EXPERIMENTAL
Intervention: Shockwave therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (rehabilitative exercises)
Number of subjects: 30
Study: 27274213

Group type: EXPERIMENTAL
Intervention: Phacoemulsification through a small pupil using minimal iris manipulation
Number of subjects: 123

Group type: COMPARATOR
Intervention: Phacoemulsification through a well-dilated pupil
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 123
Study: 25335251

Group type: EXPERIMENTAL
Intervention: Comprehensive therapy group (electroacupuncture at qi streets acupoints combined with spinal regulation method)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comprehensive therapy group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comprehensive therapy group and medication group
Number of subjects: 60
Study: 23910646

Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg/day with peginterferon alfa plus ribavirin
Number of subjects: 37

Group type: COMPARATOR
Intervention: Peginterferon alfa plus ribavirin (Control)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Simvastatin users (not randomized) with peginterferon/ribavirin
Number of subjects: 37
Study: 20675955

Group type: EXPERIMENTAL
Intervention: 4 mg/day pitavastatin
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: 20 mg/day atorvastatin
Number of subjects: 251

Group type: COMPARATOR
Intervention: Lower HDL-cholesterol levels
Number of subjects: 251
Study: 18947913

Group type: EXPERIMENTAL
Intervention: Experimental condition (fining minors for possessing or using tobacco)
Number of subjects: 25404

Group type: COMPARATOR
Intervention: Control condition (reducing commercial sources of youth access to tobacco)
Number of subjects: 25404
Study: 17060212

Group type: EXPERIMENTAL
Intervention: Multifaceted hygiene programme including educational activities and environmental changes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving the hygiene programme after the study
Number of subjects: 0
Study: 12788962

Group type: EXPERIMENTAL
Intervention: Long-acting β2-agonists (salmeterol or formoterol) used as second-line treatment for 1 week or more
Number of subjects: 596

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 596
Study: 11105182

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 104

Group type: COMPARATOR
Intervention: Minimal needling
Number of subjects: 104

Group type: COMPARATOR
Intervention: Antiemetic pharmacotherapy alone
Number of subjects: 104
Study: 8731623

Group type: EXPERIMENTAL
Intervention: General practice education/advice
Number of subjects: 130

Group type: COMPARATOR
Intervention: Hospital treatment and education/advice
Number of subjects: 130
Study: 1574950

Group type: EXPERIMENTAL
Intervention: Simvastatin 10‐40 mg/day
Number of subjects: 10
Study: 3889261

Group type: EXPERIMENTAL
Intervention: trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 90

Group type: COMPARATOR
Intervention: amoxicillin
Number of subjects: 90
Study: 31676258

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 145

Group type: COMPARATOR
Intervention: TRAD group
Number of subjects: 145
Study: 30870279

Group type: EXPERIMENTAL
Intervention: Midurethral sling placement during surgery
Number of subjects: 152

Group type: COMPARATOR
Intervention: No midurethral sling placement during surgery
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Model including preoperative stress test
Number of subjects: 152
Study: 28870887

Group type: COMPARATOR
Intervention: REST
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 15-min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30-min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 45-min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All exercise trials
Number of subjects: 12
Study: 26401946

Group type: EXPERIMENTAL
Intervention: Macular pigment (MP) measurement
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Serum lutein (L) concentrations
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Serum zeaxanthin (Z) concentrations
Number of subjects: 226
Study: 23273405

Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol 250/10 μg b.i.d.
Number of subjects: 395
Study: 22248464

Group type: EXPERIMENTAL
Intervention: Photogrammetric method for assessing body posture
Number of subjects: 563
Study: 19278300

Group type: EXPERIMENTAL
Intervention: 375 μg interferon-β-1b
Number of subjects: 145

Group type: COMPARATOR
Intervention: 250 μg interferon-β-1b
Number of subjects: 145
Study: 16441324

Group type: EXPERIMENTAL
Intervention: Instructor:student ratio of 6:12
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Instructor:student ratio of 3:12
Number of subjects: 108

Group type: COMPARATOR
Intervention: Instructor:student ratio of 1:12
Number of subjects: 108
Study: 15292625

Group type: EXPERIMENTAL
Intervention: Group psychotherapy or social support group (intervention program)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Social support group (intervention program)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 69
Study: 11691573

Group type: EXPERIMENTAL
Intervention: Isepamicin at 7.5 mg/kg i.v. q 12 h
Number of subjects: 39

Group type: COMPARATOR
Intervention: Amikacin at 7.5 mg/kg i.v. q 12 h
Number of subjects: 39
Study: 9116986

Group type: EXPERIMENTAL
Intervention: Advance directive education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8131769

Group type: EXPERIMENTAL
Intervention: Captopril, 25 mg three times daily
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 78
Study: 3312530

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active treatment groups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29037093

Group type: EXPERIMENTAL
Intervention: Anterolateral approach
Number of subjects: 51

Group type: COMPARATOR
Intervention: Direct lateral approach
Number of subjects: 51
Study: 27912871

Group type: EXPERIMENTAL
Intervention: Chamomile extract 1500mg/day for up to 8 weeks
Number of subjects: 179
Study: 24711481

Group type: EXPERIMENTAL
Intervention: Rate-responsive single chamber pacing (n=707)
Number of subjects: 1415

Group type: COMPARATOR
Intervention: Rate-responsive dual chamber pacing (n=708)
Number of subjects: 1415

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1415

Group type: EXPERIMENTAL
Intervention: Patients who experienced syncope post pacemaker implant
Number of subjects: 1415
Study: 23078636

Group type: EXPERIMENTAL
Intervention: Temptation to drink (self-reported measure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temptation to drink (self-reported measure during the fourth session of treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dichotomous measure of temptation to drink (not at all tempted vs. all other levels)
Number of subjects: 0
Study: 20948590

Group type: EXPERIMENTAL
Intervention: Tongue Base Reduction with Thyro-Hyoido-Pexy (TBRTHP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tongue Base Reduction with Hyo-Epiglottoplasty (TBRHE)
Number of subjects: 12
Study: 18373146

Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Internet intervention
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Pamphlet intervention
Number of subjects: 161

Group type: COMPARATOR
Intervention: All interventions (video, internet, pamphlet)
Number of subjects: 161